We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
33 hedge funds and large institutions have $1.32M invested in Cardiff Oncology in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
14% more funds holding
Funds holding: 29 → 33 (+4)
10% more capital invested
Capital invested by funds: $1.21M → $1.32M (+$115K)
3.76% less ownership
Funds ownership: 5.29% → 1.53% (-3.8%)
Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$310K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$158K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$101K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.4K |
| 5 |
DY
Dowling & Yahnke
San Diego,
California
|
+$49.2K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$471K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$237K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$4.15K |
| 4 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$1.74K |
| 5 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$1K |
